| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/26/2004 | US20040037805 DNA (RNA) encoding such chemokine polypeptides and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such chemokine polypeptides for the treatment of |
| 02/26/2004 | DE10231655A1 Transplantat-Akzeptanz induzierende Zellen monozytären Ursprungs, sowie deren Herstellung und Verwendung Transplant acceptance inducing cells of monocytic origin and their preparation and use |
| 02/26/2004 | DE10225139A1 Verfahren zur Identifizierung von immunreaktiven Peptiden A method for identifying immunoreactive peptides |
| 02/26/2004 | CA2535760A1 Apicomplexan pathways, inhibitiors, and drug delivery |
| 02/26/2004 | CA2535748A1 Pthrp-derived modulators of smooth muscle proliferation |
| 02/26/2004 | CA2507486A1 .alpha.(1,3)-galactosyltransferase null cells, methods of selecting and .alpha.(1,3)-galactosyltransferase null swine produced therefrom |
| 02/26/2004 | CA2497304A1 Bmp-2 estrogen responsive element and methods of using the same |
| 02/26/2004 | CA2495824A1 Ex-vivo expansion of hematopoietic stem cell populations in mononuclear cell cultures |
| 02/26/2004 | CA2495584A1 A method of characterizing dendritic cells |
| 02/26/2004 | CA2495411A1 Real time measurement of cellular responses |
| 02/26/2004 | CA2495185A1 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms |
| 02/26/2004 | CA2495177A1 Novel n-acetylgalactosamine transferases and nucleic acids encoding the same |
| 02/26/2004 | CA2494971A1 Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use |
| 02/26/2004 | CA2493822A1 Methods and compositions for targeting secretory lysosomes |
| 02/26/2004 | CA2492932A1 Methods for inducing targeted stimulation of meiotic recombination and kits for performing said methods |
| 02/26/2004 | CA2492524A1 Humanized rabbit antibodies |
| 02/25/2004 | EP1391729A1 Antitumor antigen against htlv-1 tumor or antigen epitope thereof |
| 02/25/2004 | EP1391516A1 Von willebrand factor (vwf)-cleaving enzyme |
| 02/25/2004 | EP1391513A1 IL-7 drug substance, IL-7 comprising composition, preparation and uses thereof |
| 02/25/2004 | EP1391511A1 Artificial human chromosome containing human antibody lambda light chain gene |
| 02/25/2004 | EP1391509A1 Transformed silkworm producing human collagen |
| 02/25/2004 | EP1391506A1 Animal with gene hypoexpression |
| 02/25/2004 | EP1391505A1 Stem cells and method of separating the same |
| 02/25/2004 | EP1391504A1 CD4+ CD25- T cells and Tr1-like regulatory T cells |
| 02/25/2004 | EP1391503A1 A method of cell re-programming by cytoplasmic transfer |
| 02/25/2004 | EP1391211A1 Chondrogenesis promoters |
| 02/25/2004 | EP1391210A2 Regulatory medicament comprising CD4+CD25- T cells and Tr1-like regulatory cells |
| 02/25/2004 | EP1390754A1 Method and composition for skin grafts |
| 02/25/2004 | EP1390744A2 Isolation and identification of mouse and human transcription control elements associated with cytochrome expression |
| 02/25/2004 | EP1390548A2 Cells for detection of enteroviruses |
| 02/25/2004 | EP1390543A2 New polynucleotides and polypeptides of the ifnalpha-17 gene |
| 02/25/2004 | EP1390516A1 Novel expression vectors and uses thereof |
| 02/25/2004 | EP1390511A2 Enhanced production of recombinant proteins by transient transfection of suspension-growing mammalian cells |
| 02/25/2004 | EP1390508A2 A retinoic acid metabolizing cytochrome p450 |
| 02/25/2004 | EP1390505A2 Antigens of group b streptococcus and corresponding dna fragments |
| 02/25/2004 | EP1390502A2 Interferon-alpha induced gene |
| 02/25/2004 | EP1390499A2 Cell visual characteristic-modifying sequences |
| 02/25/2004 | EP1390496A2 Glutamate receptor modulatory proteins and nucleic acids encoding them |
| 02/25/2004 | EP1390490A2 Muscle-specific expression vectors |
| 02/25/2004 | EP1390483A2 Gene encoding molecular motor protein and diagnosis method for the disease related to the gene |
| 02/25/2004 | EP1390475A2 Neutral progenitor cells |
| 02/25/2004 | EP1390474A1 Method for obtaining antigen-specific tr1 regulatory lymphocytes |
| 02/25/2004 | EP1390473A2 Methods and reagents for cell transplantation |
| 02/25/2004 | EP1390471A1 Method for autologous transplantation |
| 02/25/2004 | EP1390468A2 Identification of essential genes of aspegillus fumigatus and methods of use |
| 02/25/2004 | EP1390410A1 Molecules for disease detection and treatment |
| 02/25/2004 | EP1390409A2 Monoclonal antibody neutralising cathepsin b activity and uses thereof |
| 02/25/2004 | EP1390407A2 The lectin-like domain of thrombomodulin and its therapeutic use |
| 02/25/2004 | EP1390406A2 Method of modulating the proliferation of medullary thyroid carcinoma cells |
| 02/25/2004 | EP1390404A2 Interleukin-1 related gene and protein |
| 02/25/2004 | EP1390398A2 Adenovirus protein ix, its domains involved in capsid assembly, transcriptional activity and nuclear reorganization |
| 02/25/2004 | EP1390394A2 Compositions and methods for recombinational cloning of nucleic acid molecules |
| 02/25/2004 | EP1390392A1 Methods to inhibit viral replication |
| 02/25/2004 | EP1390391A1 Transporters and ion channels |
| 02/25/2004 | EP1390389A2 Cripto blocking antibodies and uses thereof |
| 02/25/2004 | EP1390384A2 Chromosome-based platforms |
| 02/25/2004 | EP1390379A1 Kindling fluorescent proteins and methods for their use |
| 02/25/2004 | EP1390076A1 Maturation of antigen-presenting cells using activated t cells |
| 02/25/2004 | EP1390075A2 Chemotherapeutic induction of egr-1 promoter activity |
| 02/25/2004 | EP1390065A2 Methods for promoting antigen presentation and modulating immune responses using cholera toxin and its b subunit |
| 02/25/2004 | EP1390064A2 Method of treating malignancies through induction of blood immune responses |
| 02/25/2004 | EP1390062A2 Modulators of elastase inhibitor secretion |
| 02/25/2004 | EP1390057A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and method of use |
| 02/25/2004 | EP1389997A2 Methods and compositions for stable transgenic plant pharmaceuticals and their use as contraceptives |
| 02/25/2004 | EP0981620B1 Hgf polypeptides and their use in therapy |
| 02/25/2004 | EP0929271B1 Prosthetic kidney |
| 02/25/2004 | EP0877818B1 Process for activating a kinase |
| 02/25/2004 | EP0866861B1 Molecular cloning and characterization of molecules related to relaxin and the insulin family of ligands |
| 02/25/2004 | EP0820515B1 Phospholipase c homolog |
| 02/25/2004 | EP0790059B1 Means for treating auto-immune diseases |
| 02/25/2004 | EP0751957B1 Peptide fragments of microbial stress proteins and pharmaceutical composition made thereof for the treatment and prevention of inflammatory diseases |
| 02/25/2004 | EP0665888B1 Ryegrass pollen allergen |
| 02/25/2004 | CN1478146A Calcium binding proteins |
| 02/25/2004 | CN1478145A Differentiated cells suitable for human therapy |
| 02/25/2004 | CN1478098A Modulation of IL-2-and IL-15-mediated T cell responses |
| 02/25/2004 | CN1478097A Method and cell for detecting modulations of RGS proteins |
| 02/25/2004 | CN1477983A Microstructures for treating and conditioning skin |
| 02/25/2004 | CN1477979A Tissue equivalant for transplantation and process for producing the same |
| 02/25/2004 | CN1477969A Chemokine mutants in treatment of multiple sclerosis |
| 02/25/2004 | CN1477191A Perparation method of microencapsulation fetal liver cell suspension |
| 02/25/2004 | CN1477190A Method and relative composition for controlling cell fusion |
| 02/25/2004 | CN1476903A Allogenic tissue engineered cartilage and its application |
| 02/25/2004 | CN1139655C Immortal human ovary carcinoma cell strain and its establishment method |
| 02/25/2004 | CN1139654C Establishing method of active cell strain for quantitative determination of bone morphogenetic protein (BMP) |
| 02/25/2004 | CN1139653C Process for creating medicine screening system with ABC1 gene cell target to screen 3G medicine of cardiovascular disease |
| 02/24/2004 | US6696623 Method of increasing growth and yield in plants |
| 02/24/2004 | US6696620 Immunoglobulin binding protein arrays in eukaryotic cells |
| 02/24/2004 | US6696575 Polythiophene-polypyrrole block copolymer; nervous system regeneration |
| 02/24/2004 | US6696557 Isolated nucleic acid comprising nucleotide sequence encoding extracellular domain of al-2 fused to immunoglobulin amino acid sequence |
| 02/24/2004 | US6696289 Vector having nongenomic sequences coding for multiple cloning site and 3c-protease cleavage site between first and second amino acids of long polyprotein of sabin 1 poliovirus cdna |
| 02/24/2004 | US6696272 Products and methods for gaucher disease therapy |
| 02/24/2004 | US6696270 Gastric submucosal tissue as a novel diagnostic tool |
| 02/24/2004 | US6696267 Screening compounds that modulate calcium release activated channel activity by contacting compound and calcium channel activator with calcium channel expressing cells containing reporter construct, measuring reporter gene expression |
| 02/24/2004 | US6696260 Methods to identify growth differentiation factor (GDF) binding proteins |
| 02/24/2004 | US6696257 G protein-coupled receptors from the rat and human |
| 02/24/2004 | US6696074 Harvesting animal tissue from an animal source; extracting growth and differentiation factors; inactivating infective agents of tissue; mechanically expressing undesirable components from tissue; washing tissue; drying, crosslinking |
| 02/24/2004 | US6696062 BASB006 polypeptides from Neisseria meningitidis and immunogenic compositions thereof |
| 02/24/2004 | US6695879 Cardiovascular components for transplantation and methods of making thereof |
| 02/24/2004 | US6695766 Magnetic embryo transfer |
| 02/24/2004 | CA2219081C Angiostatin fragments and aggregate angiostatin and methods of use |